Schedule 13D ownership disclosure
ENTREMED INC
Security class unavailable · CUSIP: 29382F202
Event date: 2018-04-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 13.4200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-162350
- Form type
- SC 13D
- Filer
- CASI Pharmaceuticals, Inc (DE)
- CIK
- CIK 895051
- Filed
- May 14, 2018
- Reporting period
- Apr 17, 2018
- Description
- Schedule 13D beneficial ownership